Comparable choroidal thickness between treated eyes and untreated fellow-eyes in patients with unilateral neovascular AMD: a paired-eyes comparative study.

Aims: To investigate the potential effect of anti-VEGF treatment on choroidal thickness (CT) in unilateral neovascular age-related macular degeneration (AMD) patients.

Method: This is a cross-sectional study where patients were included as part of an ongoing prospective study which included patients with unilateral neovascular (n) AMD. The fellow-eye served as control.

[Treatment of age-related macular degeneration: new insights and developments].

Age-related macular degeneration (AMD) is a highly prevalent retinal disease in the elderly with a potential deleterious effect on quality of life. Since the introduction of intra-ocular anti-vascular endothelial growth factor (anti-VEGF) injections, wet AMD has become a manageable disease. Unfortunately, not all patients can be managed with existing treatment options.